Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients

VAD therapy successfully decreases pulmonary hypertension, even in patients with “fixed” FPH, allowing candidacy for heart transplantation. Among bridge-to-transplant candidates, the presence of FPH does not reduce post-transplant survival.